Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06650826
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-16
Brief Title:
Study Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous andor Arterial Thrombosis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The APIT Study Prospective Observational Study of the Incidence of Anti-platelet Factor 4 Antibodies in Suspected Immune-associated Arterial andor Venous Thrombosis
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prospective investigation of the incidence of anti-platelet factor 4 antibodies in suspected immune-associated arterial andor venous thrombosis
Detailed Description:
Patients with venous andor arterial thrombosis aged 18 to 60 years are includedThromboses should have occurred spontaneously or within 30 days after an infection or vaccination In addition patients with recurrent thrombosis despite anticoagulation are also included in the study The primary aim of the study is to determine the incidence of anti-platelet factor 4 antibodies in relation to venous andor arterial thrombosis For this purpose we will take a blood sample from the patients within 120 days of the occurrence of the thrombosis
As a secondary objective platelet count D-dimer and results of a thrombophilia screening as well as thrombosis localization are recorded
As a secondary objective platelet count D-dimer and results of a thrombophilia screening as well as thrombosis localization are recorded
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None